Cells belonging to resolution 1 clusters, where less than 20% of the published AP-centric neuronal populations mapped to were removed from the DVC neuronal atlas
GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging
Many people find that even without insurance coverage, compounded semaglutide costs less than a single month of brand-name alternatives, and savings compound over a year of treatment
The new warning about knockoffs of Ozempic and similar drugs, which have seen demand surge over their use for weight loss, comes after a counterfeit Ozempic injector pen was discovered being sold at a U.S
These biological factors often override behavioral interventions, making weight maintenance challenging without pharmacological support